Showing results (561-570 of 2,326) with videos related to

Sort By:
Pageof 233
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1996
Treatment of human B-cell precursor leukemia in SCID mice using a combination of the investigational biotherapeutic agent B43-PAP with cytosine arabinosideY Messinger, Y Yanishevski, V I Avramis, et al.
Leukemia & Lymphoma|December 24, 1997
Large scale manufacturing of TXU(anti-CD7)-pokeweed antiviral protein (PAP) immunoconjugate for clinical trialsD E Myers, X Jun, D Clementson, et al.
Science (New York, N.Y.)|February 10, 1995
Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinasesF M Uckun, W E Evans, C J Forsyth, et al.
The Journal of Biological Chemistry|March 15, 1996
Physical and functional interactions between Lyn and p34cdc2 kinases in irradiated human B-cell precursorsF M Uckun, L Tuel-Ahlgren, K G Waddick, et al.
Leukemia & Lymphoma|August 26, 1998
In vivo toxicity and pharmacokinetic features of B43(Anti-CD19)-Genistein immunoconjugateO Ek, Y Yanishevski, T Zeren, et al.
Pageof 233